Cephalexin Safety in Myasthenia Gravis

Introduction to Cephalexin Safety

The American College of Physicians recommends that cephalexin is considered safe to use in patients with myasthenia gravis, as it does not trigger or exacerbate the condition 1

The most authoritative guideline addressing drug safety in myasthenia gravis patients specifically identifies medications that should be avoided, including fluoroquinolones, aminoglycosides, and macrolide antibiotics, but cephalosporins like cephalexin are notably absent from this list 1
Cephalosporins, such as cephalexin, work through different mechanisms than the drugs known to worsen myasthenia gravis, and do not interfere with neuromuscular transmission 1

Cephalexin maintains its antibacterial activity through beta-lactam ring-mediated bacterial cell wall synthesis inhibition, and does not operate through mechanisms that worsen myasthenia gravis, such as pre- or postsynaptic ion channel effects, acetylcholinesterase interference, or direct neuromuscular junction blockade 2

Cross-reactivity between penicillins and cephalosporins is low (2-4%) and primarily relates to allergic reactions, not myasthenia gravis exacerbation 2

Cephalexin can be used without specific myasthenia gravis-related precautions, and standard dosing applies, with a recommended dose of 500 mg three to four times daily for skin/soft tissue infections 3
It is recommended to avoid the truly contraindicated antibiotics, including fluoroquinolones, aminoglycosides, and macrolides, in patients with myasthenia gravis 1